Sponsors
The bill quickly expands naloxone access, training, and overdose surveillance in schools—directing limited resources to high-need areas and improving data for public-health response—but does so with short-term funding and new reporting/compliance requirements that may burden small schools, local health departments, and raise privacy concerns.
Students and school staff in participating schools gain ready access to opioid overdose reversal drugs (naloxone), increasing chances of reversing overdoses on school grounds.
Schools receive federal grant funding to develop and deliver CPR, overdose response, and prevention programming, improving emergency readiness and student/community education.
Resources are prioritized to areas with high opioid-overdose rates so limited funds and supplies are directed toward communities with the greatest demonstrated need.
Schools receive only one-year grants, creating a high risk that naloxone supplies, training, and programs will lapse after funding ends and leaving sustainability gaps.
New application, assurance, distribution-reporting, and compliance requirements will create administrative burdens and costs (staff time, software/training) that disproportionately strain small or under-resourced schools and LEAs.
Requiring private schools and LEAs to consult with local health departments and implement emergency plans could strain limited local public health staff and resources.
Based on analysis of 3 sections of legislative text.
Authorizes one-year competitive grants to purchase opioid overdose reversal drugs and support training for K–12 schools, and requires federally funded schools to report any distribution to NEMSIS and ODMAP.
Introduced March 19, 2026 by Raul Ruiz · Last progress March 19, 2026
Creates a short, focused federal program to help K–12 schools and school districts buy opioid overdose reversal drugs (e.g., naloxone) and provide training and prevention programs. It awards one-year competitive grants (starting within 90 days of enactment) to eligible entities, prioritizing areas with high overdose rates, and requires schools that receive federal funds to report any distributions of overdose-reversal drugs to two national data systems.